A new study found that loss of employment after diagnosis of early-stage breast cancer may be related to the type of treatments patients received.
Researchers studied 2290 women who were diagnosed with nonmetastatic breast cancer. Of the women, 746 worked for pay before diagnosis. After a four-year follow-up, 236 out of the 746 were no longer working. Women who received chemotherapy were less likely to be working at follow-up and 1.4-times more likely to be subsequently unemployed.
“We need to ensure that patients who are deciding on whether to receive chemotherapy understand the potential long-term consequences of receiving treatment, including possible implications for their employment and financial outcomes,” Reshma Jagsi, MD, University of Michigan Health System, was quoted as saying.